US 10729688
Hepatitis B antiviral agents
granted A61KA61K31/4985A61K31/7105
Quick answer
US patent 10729688 (Hepatitis B antiviral agents) held by Enanta Pharmaceuticals, Inc. expires Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- Enanta Pharmaceuticals, Inc.
- Grant date
- Tue Aug 04 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Jul 30 2040 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 19
- CPC classes
- A61K, A61K31/4985, A61K31/7105, A61K45/06